Connective Tissue Disorders at IDC 2027

Connective Tissue Disorders encompass a diverse group of conditions that affect the body's connective tissues, including skin, joints, blood vessels, and organs. These disorders can be genetic or acquired and often involve abnormalities in the structure or function of collagen, elastin, or other components of the connective tissue matrix. One of the most well-known connective tissue disorders is Ehlers-Danlos syndrome, characterized by hypermobility of joints, skin hyperextensibility, and tissue fragility. Another example is Marfan syndrome, which affects the connective tissue in the heart, blood vessels, and skeletal system, leading to features such as tall stature, long limbs, and cardiovascular complications. Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disorder that can affect multiple organs, including the skin, joints, kidneys, and heart. Scleroderma, also known as systemic sclerosis, involves abnormal collagen deposition leading to skin thickening, joint stiffness, and internal organ involvement. It may include medications to manage symptoms such as pain, inflammation, and immune dysfunction. Physical therapy and lifestyle modifications can help improve joint function and mobility. In some cases, surgery may be necessary to correct deformities or complications associated with connective tissue disorders. Early diagnosis and intervention are crucial for optimizing outcomes and preventing long-term complications. Research into the underlying mechanisms of connective tissue disorders is ongoing, with the goal of developing targeted therapies that address the underlying causes of these conditions. Additionally, support groups and patient advocacy organizations play a vital role in providing resources and support for individuals living with connective tissue disorders and their families.